Jefferies Financial Group’s Pacira BioSciences PCRX Stock Holding History

Jefferies Financial Group’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500	Closed	-$7.53K	–	1776
2024 Q3	$7.53K	Sell	500 -76,100	-99%	-$1.3M	﹤0.01%	1389
2024 Q2	$2.19M	Buy	76,600 +5,000	+7%	+$142K	0.02%	521
2024 Q1	$2.09M	Hold	71,600	–	–	0.02%	578
2023 Q4	$2.42M	Sell	71,600 -2,800	-4%	-$81.9K	0.02%	638
2023 Q3	$2.28M	Buy	74,400 +52,400	+238%	+$1.89M	0.02%	581
2023 Q2	$882K	Sell	22,000 -18,500	-46%	-$765K	0.01%	969
2023 Q1	$1.65M	Hold	40,500	–	–	0.01%	723
2022 Q4	$1.56M	Buy	+40,500	New	+$1.97M	0.01%	739

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jefferies Financial Group's PCRX Position: Q2 2026 in Review

Jefferies Financial Group increased its Pacira BioSciences (PCRX) stake by 89% in Q2 2026, buying an estimated $4.11M and bringing the position to 370,092 shares worth $9.39M. The position accounts for 0.06% of the portfolio, ranked #261.

Jefferies Financial Group first reported a position in PCRX in Q4 2022 and has held it in 15 quarters since. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Jefferies Financial Group held 370,092 shares of Pacira BioSciences worth $9.39M as of Q2 2026.
Jefferies Financial Group bought 173,800 Pacira BioSciences shares in Q2 2026, an estimated $4.11M.
Pacira BioSciences made up 0.06% of Jefferies Financial Group's portfolio in Q2 2026, its #261 holding.
Jefferies Financial Group first reported a position in Pacira BioSciences in Q4 2022 and has held it in 15 quarters since.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.